Sowell Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
2,797
-29
| -1% | -$12.9K | 0.05% | 358 |
|
|
2025
Q1 | $1.37M | Buy |
+2,826
| New | +$1.37M | 0.06% | 307 |
|
|
2023
Q2 | – | Sell |
-3,188
| Closed | -$1M | – | 835 |
|
|
2023
Q1 | $1M | Buy |
+3,188
| New | +$1M | 0.08% | 292 |
|
|
2021
Q2 | – | Sell |
-2,529
| Closed | -$539K | – | 2697 |
|
|
2021
Q1 | $539K | Buy |
2,529
+83
| +3% | +$17.7K | 0.02% | 616 |
|
|
2020
Q4 | $578K | Buy |
2,446
+283
| +13% | +$66.9K | 0.02% | 483 |
|
|
2020
Q3 | $589K | Buy |
2,163
+8
| +0.4% | +$2.18K | 0.03% | 432 |
|
|
2020
Q2 | $626K | Buy |
2,155
+368
| +21% | +$107K | 0.03% | 393 |
|
|
2020
Q1 | $425K | Sell |
1,787
-870
| -33% | -$207K | 0.03% | 432 |
|
|
2019
Q4 | $582K | Buy |
2,657
+489
| +23% | +$107K | 0.04% | 405 |
|
|
2019
Q3 | $367K | Buy |
+2,168
| New | +$367K | 0.03% | 485 |
|
|
2019
Q1 | $323K | Hold |
1,758
| – | – | 0.04% | 435 |
|
|
2018
Q4 | $291K | Buy |
1,758
+401
| +30% | +$66.4K | 0.04% | 393 |
|
|
2018
Q3 | $262K | Buy |
1,357
+50
| +4% | +$9.65K | 0.04% | 285 |
|
|
2018
Q2 | $229K | Buy |
+1,307
| New | +$229K | 0.05% | 256 |
|
|
2017
Q3 | – | Sell |
-2,762
| Closed | -$423K | – | 284 |
|
|
2017
Q2 | $423K | Hold |
2,762
| – | – | 0.12% | 154 |
|
|
2017
Q1 | $325K | Buy |
2,762
+23
| +0.8% | +$2.71K | 0.1% | 179 |
|
|
2016
Q4 | $245K | Buy |
+2,739
| New | +$245K | 0.08% | 170 |
|